Karen Medina-Quero

7PUBLICATIONS
31CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsBiocatalysis and enzyme technologySequence analysisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2025
TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes.

Lucero A Ramón-Luing, Laura Edith Martínez-Gómez, Carlos Martinez-Armenta

|Jan 27, 2024
Aptamers: A Cutting-Edge Approach for Gram-Negative Bacterial Pathogen Identification.

María Guadalupe Córdova-Espinoza, Rosa González-Vázquez, Rolando Rafik Barron-Fattel

|Apr 28, 2023
The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B.

Leslie Chavez-Galan, Andy Ruiz, Lucero A Ramón-Luing

|Dec 22, 2022
In silico selection of aptamers for bacterial toxins detection.

Alejandro Escamilla-Gutiérrez, María Guadalupe Córdova-Espinoza, Anahí Sánchez-Monciváis

|Jan 11, 2022
Mycobacterium tuberculosis H37Rv Strain Increases the Frequency of CD3+TCR+ Macrophages and Affects Their Phenotype, but Not Their Migration Ability.

Lucero A Ramon-Luing, Claudia Carranza, Norma A Téllez-Navarrete

|Aug 27, 2021
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality.

Yadira Palacios, Andy Ruiz, Lucero A Ramón-Luing

Pageof 2